Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04064294 · ClinicalTrials.gov registry record
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 93
- Enrollment target
NCT04064294: Completed study, sponsored by VA Office of Research and Development.
NCT04064294 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04064294 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
In this study, the investigators will examine the association of statin use and dyskinesia in a convenience sample Parkinson's disease patients in the Veterans Administration Health Care System.
Interventions
- DRUG Intravenous Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04064294
The ClinicalTrials.gov registry entry for NCT04064294 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous Infusion is the first listed.
NCT04064294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04064294 about?
NCT04064294 is a clinical study titled "Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors". In this study, the investigators will examine the association of statin use and dyskinesia in a convenience sample Parkinson's disease patients in the Veterans Administration Health Care System.
What is the current status of trial NCT04064294?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2019-08-22. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04064294?
The interventions under investigation include: Intravenous Infusion (DRUG).
Who is sponsoring clinical trial NCT04064294?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.